Literature DB >> 8384379

How silicosis and coal workers' pneumoconiosis develop--a cellular assessment.

N L Lapp1, V Castranova.   

Abstract

In vitro and in vivo animal studies, as well as human investigations, strongly support the role of macrophage products in the development and progression of silicosis and coal workers' pneumoconiosis. Such products include enzymes and reactive oxygen species which may cause lung damage; cytokines which recruit and/or activate polymorphonuclear leukocytes and thus result in further oxidant damage to the lung; and fibrogenic factors which induce fibroblast proliferation and collagen synthesis. This mechanistic understanding of pulmonary disease should assist in developing strategies for prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384379

Source DB:  PubMed          Journal:  Occup Med        ISSN: 0885-114X


  21 in total

1.  Gender influences the response to experimental silica-induced lung fibrosis in mice.

Authors:  David M Brass; Sean P McGee; Mary K Dunkel; Sarah M Reilly; Jacob M Tobolewski; Tara Sabo-Attwood; Cheryl L Fattman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-20       Impact factor: 5.464

2.  Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura.

Authors:  Fiona A Murphy; Craig A Poland; Rodger Duffin; Khuloud T Al-Jamal; Hanene Ali-Boucetta; Antonio Nunes; Fiona Byrne; Adriele Prina-Mello; Yuri Volkov; Shouping Li; Stephen J Mather; Alberto Bianco; Maurizio Prato; William Macnee; William A Wallace; Kostas Kostarelos; Ken Donaldson
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

3.  Nitric oxide production by rat bronchoalveolar macrophages or polymorphonuclear leukocytes following intratracheal instillation of lipopolysaccharide or silica.

Authors:  L J Huffman; D J Prugh; L Millecchia; K C Schuller; S Cantrell; D W Porter
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

4.  Pulmonary inflammation and crystalline silica in respirable coal mine dust: dose-response.

Authors:  E D Kuempel; M D Attfield; V Vallyathan; N L Lapp; J M Hale; R J Smith; V Castranova
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

Review 5.  Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Authors:  Eileen D Kuempel; Marie-Claude Jaurand; Peter Møller; Yasuo Morimoto; Norihiro Kobayashi; Kent E Pinkerton; Linda M Sargent; Roel C H Vermeulen; Bice Fubini; Agnes B Kane
Journal:  Crit Rev Toxicol       Date:  2016-08-18       Impact factor: 5.635

6.  Nitric oxide up-regulates DNA-binding activity of nuclear factor-kappaB in macrophages stimulated with silica and inflammatory stimulants.

Authors:  J L Kang; K Lee; V Castranova
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

7.  Effect of inhaled crystalline silica in a rat model: time course of pulmonary reactions.

Authors:  Vincent Castranova; Dale Porter; Lyndell Millecchia; Jane Y C Ma; Ann F Hubbs; Alexander Teass
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

8.  Attenuation of acute inflammatory effects of silica in rat lung by 21-aminosteroid, U74389G.

Authors:  J M Antonini; K van Dyke; M DiMatteo; M J Reasor
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

9.  Phosphoinositide 3-kinase activity leads to silica-induced NF-kappaB activation through interacting with tyrosine-phosphorylated I(kappa)B-alpha and contributing to tyrosine phosphorylation of p65 NF-kappaB.

Authors:  Jihee Lee Kang; Hui Su Lee; In Soon Pack; Kyu Chung Hur; Vincent Castranova
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

Review 10.  Silica binding and toxicity in alveolar macrophages.

Authors:  Raymond F Hamilton; Sheetal A Thakur; Andrij Holian
Journal:  Free Radic Biol Med       Date:  2007-12-27       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.